73 results
POS AM
BFLY
Butterfly Network, Inc.
8 Aug 23
Prospectus update (post-effective amendment)
5:19pm
through focused clinical trials.
In order to conduct a clinical investigation involving human subjects for the purpose of demonstrating the safety … other things, apply for and obtain institutional review board (“IRB”) approval of the proposed investigation. In addition, if the clinical study
S-3
EX-4.6
BFLY
Butterfly Network, Inc.
8 Aug 23
Shelf registration
5:11pm
or rights or powers conferred upon it by this Indenture;
(f) The Trustee shall not be bound to make any investigation into the facts or matters stated … a reasonable time to the Trustee of the costs, expenses, claims or liabilities likely to be incurred by it in the making of such investigation
S-3
EX-4.5
BFLY
Butterfly Network, Inc.
8 Aug 23
Shelf registration
5:11pm
investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, consent, order … by it in the making of such investigation is, in the opinion of the Trustee, not reasonably assured to the Trustee by the security afforded
POS AM
BFLY
Butterfly Network, Inc.
2 May 23
Prospectus update (post-effective amendment)
6:09am
or services, we anticipate that we will need to validate at-home applications through focused clinical trials.
In order to conduct a clinical investigation … ”) approval of the proposed investigation. In addition, if the clinical study involves a “significant risk” (as defined by the FDA) to human health
424B3
5onyjfa9rns7 mj7o7
2 May 22
Prospectus supplement
5:06pm
POS AM
hn3fqsqbp7adnorhbhs3
19 Apr 22
Prospectus update (post-effective amendment)
5:30pm
8-K/A
EX-10.1
4sj7z8 1j6zidwzkou4
28 Mar 22
Results of Operations and Financial Condition
6:34am
8-K/A
EX-10.1
ynq3q
28 Mar 22
Departure of Directors or Certain Officers
6:21am
8-K/A
EX-10.1
727okg
28 Mar 22
Entry into a Material Definitive Agreement
6:16am
424B3
9189ggor no8o
4 Feb 22
Prospectus supplement
4:27pm
8-K
EX-10.1
sxxu4101pt86a nsjt
4 Feb 22
Results of Operations and Financial Condition
4:11pm
424B3
oc1dn6f
15 Nov 21
Prospectus supplement
12:00am
424B3
sg9ezu4pjr1e
9 Aug 21
Prospectus supplement
4:54pm